TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pro Health Pharma Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,141
|
1,945
|
1,743 |
| Financial expenses |
12
|
15
|
1 |
| Earnings before taxes |
303
|
60
|
101 |
| EBITDA |
357
|
75
|
147 |
| Total assets |
1,115
|
1,479
|
1,141 |
| Current assets |
923
|
1,235
|
998 |
| Current liabilities |
273
|
569
|
280 |
| Equity capital |
807
|
892
|
844 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
72.4%
|
60.3%
|
74.0% |
| Turnover per employee |
714
|
648
|
581 |
| Profit as a percentage of turnover |
14.2%
|
3.1%
|
5.8% |
| Return on assets (ROA) |
28.3%
|
5.1%
|
8.9% |
| Current ratio |
338.1%
|
217.0%
|
356.4% |
| Return on equity (ROE) |
37.5%
|
6.7%
|
12.0% |
| Change turnover |
262
|
197
|
137 |
| Change turnover % |
14%
|
11%
|
9% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.